Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pregabalin/tramadol - Laboratorios Silanes

Next Previous
Drug Profile

Pregabalin/tramadol - Laboratorios Silanes

Alternative Names: P/T; Tramadol/pregabalin - Laboratorios Silanes

Latest Information Update: 01 Jun 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Laboratorios Silanes
  • Class Aminobutyric acids; Analgesics; Anisoles; Antidepressants; Antiepileptic drugs; Anxiolytics; Cyclohexanols; Dimethylamines; Erectile dysfunction therapies; Gabapentinoids; Neuroprotectants; Opioid analgesics; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; CACNA2D1 protein modulators; Opioid mu receptor agonists; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Neuropathic pain

Most Recent Events

  • 31 May 2022 No development reported - Phase-I for Neuropathic pain (In volunteers, In adults) in Mexico (PO)
  • 20 Apr 2022 Laboratorios Silanes plans the phase IIIb LOBUXALIII trial in Neuropathic pain (In volunteers, In adults, In the elderly) in Mexico (PO, Tablet) (NCT05389150) (SIL-30901-III-21 (2))
  • 27 Mar 2019 Laboratorios Silanes completes a phase I trial in Neuropathic pain (In volunteers, In adults) in Mexico (PO, Tablet) (NCT05389150)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top